Pictet Asset Management Holding SA Raises Stock Position in Astrana Health, Inc. (NASDAQ:ASTH)

Pictet Asset Management Holding SA raised its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 21.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,075 shares of the company’s stock after purchasing an additional 1,273 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Astrana Health were worth $223,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Handelsbanken Fonder AB boosted its stake in shares of Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock worth $281,000 after buying an additional 400 shares during the last quarter. Swiss National Bank boosted its position in Astrana Health by 1.1% in the 4th quarter. Swiss National Bank now owns 88,444 shares of the company’s stock worth $2,789,000 after purchasing an additional 1,000 shares in the last quarter. KBC Group NV grew its stake in shares of Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after purchasing an additional 1,316 shares during the period. Moran Wealth Management LLC grew its stake in shares of Astrana Health by 21.5% during the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock worth $250,000 after purchasing an additional 1,404 shares during the period. Finally, Linden Thomas Advisory Services LLC increased its holdings in shares of Astrana Health by 23.3% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 15,247 shares of the company’s stock valued at $481,000 after purchasing an additional 2,883 shares in the last quarter. 52.77% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on ASTH. Barclays assumed coverage on shares of Astrana Health in a report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price target on the stock. Stifel Nicolaus lowered their target price on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Robert W. Baird cut their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Macquarie upgraded Astrana Health to a “hold” rating in a research report on Monday, December 16th. Finally, Truist Financial cut their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Three research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $53.29.

Astrana Health Price Performance

Shares of Astrana Health stock opened at $32.22 on Friday. The stock has a market capitalization of $1.61 billion, a P/E ratio of 24.78, a PEG ratio of 1.37 and a beta of 1.04. The business has a 50 day simple moving average of $32.47 and a two-hundred day simple moving average of $40.18. Astrana Health, Inc. has a 12 month low of $23.12 and a 12 month high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. As a group, analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.